Chemical Name | CAS Code |
---|---|
ALLUPURINOL REL COMPOUND D Allopurinol EP Impurity D O OR Allopurinol USP Related Compound D OR Ethyl 3-Amino-4-pyrazolecarboxylate | 6994-25-8 |
ALLUPURINOL REL COMPOUND D ALLUPURINOL REL COMPOUND D Allopurinol EP Impurity D O OR Allopurinol USP Related Compound D OR Ethyl 3-Amino-4- pyrazolecarboxylate | 6994-25-8 |
ALLUPURINOL IMP E OR> Allopurinol USP Related Compound E OR 3- (Formylamino)-1H-pyrazole-4-carboxylic Acid Ethyl Ester | 31055-19-3 |
ALLUPURINOL IMP E OR Allopurinol USP Related Compound E OR 3- (Formylamino)-1H-pyrazole-4-carboxylic Acid Ethyl Ester | 31055-19-3 |
ATAVAQUOENE INDENE ISOMER IMP A (WHITE VIAL) OR ATAVAQUOENE INDENE ISOMER IMP A OR 2-[trans-4-(4- Chlorophenyl)cyclohexyl]-1-oxo-1H- indene-3- carboxylic Acid | 2517583-91-2 |
ATAVAQUOENE INDENE ISOMER IMP A OR 2-[trans-4-(4- Chlorophenyl)cyclohexyl]-1-oxo-1H- | 2517583-91-2 |
ATROVASTIN IMP A OR Atorvastatin USP RC A ; Desfluoro Atorvastatin Calcium ; | 433289-83-9 (calcium salt) 433289-84-0 (acid) |
ATROVASTIN IMP D OR Atorvastatin EP Impurity D1 ; Atorvastatin USP RC D ; Atorvastatin FXA1 Impurity ; Atorvastatin Epoxydione Impurity ; Atorvastatin Diketo Epoxide Impurity | 148146-51-4 |
4-ATONDROSTEN-3-,1-TRIEKEONE OR 4-Androstenetriol;4- Androstenetrione;4-ANDROSTEN-3,6,17- TRIONE;4-ANDROSTENE-3,6,17- TRIONE;ANDROST-4-ENE-3,6,17- TRIONE;Androst-4-ene-3,6,17-trione Raw Powder;10,13-dimethyl- 1,2,7,8,9,11,12,14,15,16- decahydrocyclopenta[a]phenanthrene- 3,6,17-trione;(8R,9S,10R,13S,14S)-10,13- dimethyl-1,2,7,8,9,11,12,14,15,16- decahydrocyclopenta[a]phenanthrene- 3,6,17-trione | 2243-06-3 |
4,6-ANDROSTANDIENE OR 4, 6- ANDROSTADIEN-3, 17-DIONE | 633-34-1 |
ANDROSTAN-17-ONE OR 3β-Hydroxy-5α- androstan-17-one | 481-29-8 |
ANDROSTAN-4,6 DIENE OR 17beta- Hydroxyandrosta-4,6-dien-3-one OR Delta6-Testosterone; 17β- Hydroxyandrosta-4,6-dien-3-one; δ6- Testosterone; Testosterone-6-ene; Testosterone Related Compound I (USP); | 2484-30-2 |
ANDROSTAN-5ENE-3 | 256521-84-3 |
DELTA ANDROSTENDIONE | 897958-45-1 |
4-AMINO PHENOL Paracetamol EP Impurity K/ Mesalazine EP Impurity A | 123-30-8 |
4-CHOLORO ACETANILIDE USP Acetaminophen Related Compound J; Paracetamol EP Impurity J | 539-03-7 |
AXTINIB IMP H | 1639137-80-6 |
AXTINIB IMP C | 1959572-97-4 |
AXTINIB IMP A | 319472-78-1 |
AXTINIB IMP D | 1959572-98-5 |
AXTINIB IMP F Dihydro-Axitinib |
1443118-73-7 |
AXTINIB IMP H | 1639137-80-6 |
N-NITROSO AXITINIB (E)-N-methyl-2-((1-nitroso-3-(2-(pyridin- 2-yl)vinyl)-1H-indazol-6- yl)thio)benzamide | N/A |
APPRC -1 (3-ACETAMIDOPHTLIC ACIDWHITE VIA | 15371-06-9 |
N-NITROSO AXITINIB (E)-N-methyl-2-((1-nitroso-3-(2-(pyridin- 2-yl)vinyl)-1H-indazol-6- yl)thio)benzamide | N/A |
APRRC-3 WHITE VIAL | 2096492-41-8 |
APRRC-4 WHITE VIAL | 1809170-71-5 |
APRRC-5 (WHITE VIAL | 635705-72-5 |
AMOXCILLIAN REL COMP D | 68728-47-2 |
AMLODIPINE IMP D/Dehydro Amlodipine/USP Amlodipine Related Compound A/Amlodipine Besylate EP Impurity D | 113994-41-5 |
AZITHROMYCIN IMP P | 92594-45-1 |
AZITHROMYCIN IMP J | 117693-41-1 |
AZITHROMYCIN IMP A | 76801-85-9 |
AZITHROMYCIN IMP F | 612069-28-0 |
AZITHROMYCIN IMP G | 612069-31-5 |
AZITHROMYCIN IMP B | 307974-61-4 |
AZITHROMYCIN IMP B | 307974-61-4 |
AZITHROMYCIN IMP B (WHITE VIAL) | 307974-61-4 |
AZITHROMYCIN IMP I (N-DEMETYLAZTHRIOMYCIN) | 172617-84-4 |
AZITHROMYCIN IMP O | 763924-54-5 |
AZITHROMYCIN IMP K | 612534-95-9 |
AZITHROMYCIN IMP C | 620169-47-3 |
AZITHROMYCIN IMP D | N/A |
AZITHROMYCIN IMP O | 763924-54- |
AZITHROMYCIN IMP C | 620169-47-3 |
AZITHROMYCIN IMP D | N/A |
AZITHROMYCIN IMP K | 612534-95-9 |
3-AMIOSALYCLIC ACID | 570-23-0 |
ABACAVIR REL COMP A | 124752-25-6 |
AMOXCILLIAN REL COMP D | 68728-47-2 |
Adapalene ester (methyl) Adapalene Related Compound B; Adapalene USP Related Compound B | 106685-41-0 |
Artesunate peroxy hemiacetal | 149588-86-3 |
Abacavir Cyclopropyldiaminopurine Impurity | 120503-69-7 |
Abacavir rel comp C | 172015-79-1 |
Abacavir Sulfate WS | N/A |
Aspirin Impurity D --- Acetylsalicylsalicylic acid | 530-75-6 |
Aspirin Impurity C | CAS 69-72-7 |
Aspirin Impurity E Salsalate/ Acetylsalicylic Acid EP Impurity E | 552-94-3 |
Adapalene Impurity A (INH) --- Methyl Ester Of Adapalene | 33626-98-1 |
Alprazolam impurity C (EP/BP) | 36916-19-5 |
Alprazolam impurity G | 448950-89-8 |
Amlodipine Mesylate Monohydrate WS | N/A |
Abacavir imp A | 136470-79-6 |
Acyclovir Related Compound A / Valaciclovir EP Impurity I/ Acyclovir Impurity A | 102728-64-3 |
Aceclofenac Impurity H | 1216495-92-9 |
Aceclofenac BP.WS FOR UV &IR | N/A |
Amlodipine Impurity G | 43067-01-2 |
Acetylsalisalicylic acid | 530-75-6 |
Anhydrous lactose | N/A |
Acyclovir Related Compound A / Valaciclovir EP Impurity I/ Acyclovir Impurity A | 102728-64-3 |
Acyclovir Related Compound A / Valaciclovir EP Impurity I/ Acyclovir Impurity A | 102728-64-3 |
Aceclofenac Impurity F / Aceclofenac Benzyl Ester | 100499-89-6 |
Aspartame Related Compd A | 5262-10-2 |
Acetylcysteine imp D | 18725-37-6 |
Acetylcysteine WS | N/A |
Azithromycin N-Oxide Impurity / Azithromycin EP Impurity L | 90503-06-3 |
Amikacin Sulfate Impurity I | 40371-51-5 |
Amlodipine Impurity A /Phthaloyl amlodipine/Amlodipine Related Compound D/Amlodipine EP Impurity A | 88150-62-3 |
AMLODIPINE IMP D/Dehydro Amlodipine/USP Amlodipine Related Compound A/Amlodipine Besylate EP Impurity D | 113994-41-5 |
Amlodipine BESILATE Related Compound A | 113994-41-5 |
AMLODIPINE IMP D/Dehydro Amlodipine/USP Amlodipine Related Compound A/Amlodipine Besylate EP Impurity D | 113994-41-5 |
ABACAVIR REL COMP A | 124752-25-6 |
Abacavir Related Compound B | 141271-12-7 |
Aspartame Related Compd A | 5262-10-2 |
Aspartame Related Compd A | 5262-10-2 |
Allopurinol EP Impurity D / Allopurinol USP Related Compound D | 6994-25-8 |
Allopurinol EP Impurity D / Allopurinol USP Related Compound D | 6994-25-8 |
Acetylcysteine Impurity B/L-Cysteine | 52-90-4 |
Acetylcysteine Impurity C /Acetylcysteine USP Impurity C | 5545-17-5 |
ALBUTEROL IMPURITY O/ Salbutamol Impurity O | N/A |
2-AMINO-6-CHLOROPURINE | 10310-21-1 |
3-AMINO-3- DEOXYTHYMIDINE/Zidovudine Impurity | 52450-18-7 |
7-ACETYL PACLITAXEL/Paclitaxel EP Impurity L | 92950-39-5 |
BICYCLO BORNAPRINE | N/A |
BIS VALAYCLOVIR | 1356019-51-6 |
1-Bromo-4- Chlorobutane | 6940-78-9 |
BUPORIAN RELEATED COMPOUND F | 857233-13-7 |
BIS ANHYDRO DAUNOMYCINONE | N/A |
Bicalutamide Impurity C /Deshydroxy Bicalutamide | 906008-94-4 |
Bicalutamide Impurity L /Bicalutamide EP Impurity K / Bicalutamide EP Impurity L | N/A |
Bicalutamide Impurity K/Bicalutamide EP Impurity K / Bicalutamide EP Impurity L | N/A |
Bisoprolol N-Formyl Impurity | 1447715-45-8 |
Bosentan Hydroxy Impurity | 253688-60-7 |
Budesonide unknown impurity) (RRT 50.8(M/Z 431) | N/A |
Budesonide unknown impurity (RRT 50.8(M/Z 431) | N/A |
Budesonide unknown imp | N/A |
Budesonide API | N/A |
Befa P-7 Imp | N/A |
Betahistine im | N/A |
Baecatin | N/A |
Bupro Pk2 | N/A |
Bromhexine HCl Impurity C (N-(2-aminobenzyl)-N- methylcyclohexanamine) | 609-85-8 |
Burpopion imp 2 (RRT ABOUT 0.78) | N/A |
Beclomethasone imp A | N/A |
6-BROMO BETHAMSONE | 1186048-34-9 |
6-BROMO BETHAMSONE | 1186048-34-9 |
BUDESONIDE UNKNOWN IMPURITY | N/A |
CLOBAZAM IMP D | N/A |
4-CHOLORO ACETANILIDE | 539-03-7 |
CYCLOPROPYLAMINE | 765-30-0 |
CHLOFORL-D | 865-49-6 |
CHOLESTERY SODIUM SULPHATE | 2864-50-8 |
Clofazimine Unknown Impurity ( Oxo- Impurity) | N/A |
Citalopram Related Compound A/Escitalopram EP Impurity A/USP Citalopram Related Compound A | 64372-56-1 |
Citalopram Related Compound D | 62498-67-3 |
Citalopram Related Compound A/Escitalopram EP Impurity A/USP Citalopram Related Compound A | 64372-56-1 |
Citalopram RELATED COMPOUND D (OIL) Citalopram Related Compound D | 62498-67-3 |
Capecitabine Related Compound B / Doxifluridine | 3094-09-5 |
Capecitabine Related Compound B / Doxifluridine | 331943-04-5 |
Celecoxib Related Compound A | 170570-01-1 |
Celecoxib IMPURITY A | N/A |
Celecoxib Related Compound B / (Impurity B Isomeric Impurity | 331943-04-5 |
Celecoxib IMP B/ Celecoxib Related Compound B / (Impurity B Isomeric Impurity | 331943-04-5 |
Carvedilol imp A/ USP Carvedilol Related Impurity A; Carvedilol EP Impurity A | 1198090-73-1 |
Carvedilol RELATED COMPOUND D | N/A |
Clopidogrel Related Compound A | 144457-28-3 |
Clobetasol Propionate Impurity C | 25122-52-5 |
Ciprofloxacin Formyl Impurity | N/A |
Clopidogrel Related Compound A/ Clopidogrel EP IMP A | 144750-42-5 |
Cyclizine Impurity A - 1-Methyl piperazine /Imatinib EP Impurity G | 109-01-3 |
Ciprofloxacin impurity E / Decarboxy Ciprofloxacin | 105394-83-0 |
Clotrimazole Impurity D / Imidazole/ Ondansetron EP Impurity E | NO;288-32-4 |
Cipro E Repurify | N/A |
Citrizine N- oxide | 442863-80-1 |
Citalopram dihydro imp (CTM-I Compound) | N/A |
Clarithromycin imp H | 127140-69-6 |
Clarithromycin IMP D/ USP Clarithromycin Impurity D | 101666-68-6 |
Clarithromycin IMP D/ USP Clarithromycin Impurity D | 101666-68-6 |
CPX- pyrone | N/A |
1,3 cyclohexanedione | 504-02-9 |
Clotrimazole related comp A/ Clotrimazole USP RC A | 66774-02-5 |
Clorofluticasone | N/A |
Ciprofloxacin Hydrochloride Impurity A /Ciprofloxacin EP Impurity A | 86393-331 |
Cetirizine HCl Impurity A | N/A |
Ceftriaxone Triazine Analog /Thiotriazinone | 58909-39-0 |
Capecitabine Related Compound B | 3094-09-5 |
arbamazepine Impurity E : /10,11- Dihydro-5H-dibenz[b,f]azepine> | 494-19-9 |
Cetirizine Impurity C | AS # 83881-59-8 (base) ; 2702511-37-1 (2HCl) ; |
Ciclesonide S-isomer | N/A |
Cetirizine Impurity F (Des-Chloro) | N/A |
Cetrizine n-oxide | N/A |
Ciclesonide S-isomer | N/A |
Cinacalcet Related Compound E/3- (Trifluoromethyl)benzenepropanol | 78573-45-2 |
Carfilzomib Diol Impurity (RRT ABOUT 0.56) | N/A |
CIMETIRIAN IMP B DIMER | N/A |
N,N-DIYCLOHEXYLCARBODIIMIDE | 538-75-0 |
16-DEHYDROPREGANNOLINE ACETATE | 979-02-2 |
3,5-DIBROMMOANTHRANILIC ACID BROHEXMINE ACID IMP/ 2-Amino-3,5- dibromobenzoic Acid | 609-85-8 |
DIOSGENIN/Nitogenin | 512-04-9 |
7-CHLOROMETHYL DROSPIRONE/Drospirenone EP Impurity G | 932388-90-4 |
DAPAGLIFLOZIN PROPANEDIOL | N/A |
DAPAGLIFLOZIN KETO IMP | 2169998-23-4 |
O-DESETHYL DAPAGLIFLOZIN | 864070-37-1 |
HYDROXY DAPAGLIFLOZIN IMP | 1204222-85-4 |
1,3 DIETHYLBENZENE | 1809224-82-5 |
DEXAMATHASONE IMP K | 1809224-82-5 |
DIMETHYL SULFOXIDE-D6 | 2206-27-1 |
2,3 DICHLORO BENZOYL CYNIDE 2,3-DICHOLRO BENZOYL CYNIDE/ LAMOTRIGINE IMPURITY 1 | 77668-42-9 |
2,4 DICHLORO BENZOYL CYNIDE RRT 0.01 | 6306-60-1 |
7,8 DESACETTYL-9,10-DEHYDRO DANUROBINE | 1159977-24-8 |
3,8 dimethylacenaphthylene-12-dione | 146885-81-6 |
DIHYDROERGOTAMINE IMP D | 5550-75-4 |
DIHYDROERGOTAMINE IMP D | 5550-75-4 |
DIHYDROERGOTAMINE 0.35RRT | N/A |
DABIGATRAN N- OXIDE | N/A |
ETHYL CARBAZATE | 4114-31-2 |
DL-HOMOPHENYLALAIN | 1012-05-1 |
2,6- Dihydroxy Benzoicacid | 303-07-1 |
2,6-Dichlorobenzenesulfonyl Chloride | CAS 6579-54-0 |
DONEPRAZOL N OXIDE DELTA | 120013-84-5 |
DOCETAXEL IMP C | 153381-68-1 |
DICLOFENAC IMP A/ Aceclofenac EP Impurity I/ Diclofenac USP Related Compound A/ Indolinone/ Diclofenac Amide | 15362-40-0 |
DICLOFENAC IMPURITY F | 560075-65-2 |
DICLOFENAC Ws (DICLOFENAC POTASSIUM/ Diclofenac Acid --- # 130214_C/ DICLOFENAC WORKING STANDARD | 15307-86-5 |
DICLOFENAC D4 | 153466-65-0 |
Dacarbazine Related Compound B | 4656-86-4 |
Dantrolene Related Compd B # 170103 | 57268-33-4 |
Desbenzyl Donepezil (In-House Impurity C) | N/A |
Diclofenac Acid --- # 130214_C/ DICLOFENAC WORKING STANDARD/ DICLOFENAC Ws (DICLOFENAC POTASSIUM | 15307-86-5 |
Diclofenac Ethyl Ester --- # 130213_C | 15307-77-4 |
Diclofenac Impurity --- 2,6-Dichloroaniline | 608-31-1 |
Diclofenac Impurity 2-Chloro-N-(2,6- Dichlorophenyl)-N-phenylacetamide | 15308-01-7 |
Diclofenac Impurity A 130215 | 15362-40-0 |
Diclofenac Impurity A (Indolinone) #120613_C --- Diclofenac Related Compd A | 15362-40-0 |
Diclofenac Impurity F #140503 | 560075-65-2 |
Diclofenac Isopropyl Ester --- # 130216_C ---- # 160306 | 66370-79-4 |
Diclofenac Methyl Ester --- # 130212_C | 15307-78-5 |
Docetaxel Impurity A 100906 | 1887057-05-7 |
Donepezil N-Oxide ? RRT = 0.55 ( HPLC=97.2%) | 120013-84-5 |
Donepezil N-Oxide USP RRT=1.2 # 140604 | 120013-84-5 |
Dorzolamide Impurity B # 120803 | 149249-72-9 |
Dorzolamide Impurity D 100109/ USP Dorzolamide Related Compound D | 154154-90-2 |
Doxazosin Related Compound F/ SP Doxazosin Related Compound F; Doxazosin EP Impurity C # 130515_C | 617677-53-9 |
DP7 Impurity B | N/A |
Dutasteride - Chloro Impurity (#111213_C & HPLC=62.4%) | N/A |
(S)-Duloxetine Phthalamide Impurity/Duloxetine Phthalamide Impurity | 199191-67-8 |
DP7 Impurity A | N/A |
Desvenlafaxine | 93413-62-8 |
Diethylene Glycol Bisphthalate (Travoprost Opthalmic Solution Impurity) | 13988-26-6 |
Dacarbazine Related Compound A | 72-40-2 |
Dutasteride - Chloro Impurity | N/A |
Donepezil open ring imp | N/A |
Diclofenac rel Comp A / DICLOFENAC IMP A/ Aceclofenac EP Impurity I/ Diclofenac USP Related Compound A/ Indolinone/ Diclofenac Amide | 15362-40-0 |
2,4-Diamino-6-hydroxy-5-nitropyrimidine | 2387-48-6 |
DP7 Impurity D | N/A |
Diclofenac benzoic acid | N/A |
Emtricitabine Carboxylic Acid Impurity | 1238210-10-0 |
Emtricitabine Hydroxy Compound | N/A |
Emtricitabine Hydroxy Impurity SAMPLE 4 | N/A |
Emtricitabine Hydroxy Impurity | N/A |
Emtricitabine Sulfoxide Impurity | 152128-773 |
Emtricitabine Carboxylic Acid Impurity | 1238210-10-0 |
Emtricitabine Hydroxy Compound | N/A |
Efavirenz Amino Alcohol Impurity | N/A |
Emtricitabine Hydroxy (FTU) Impurity | N/A |
Emtricitabine Carboxylic Acid Impurity | 1238210-10-0 |
Etacrynic Acid Impurity B | 27929-18-6 |
Emtricitabine Carboxylic Acid Impurity | 1238210-10-0 |
Emtricitabine carbohydroxy impurity | N/A |
Erdosteine Imp EP21506 | N/A |
Erdosteine Metabolite 1 | N/A |
Erdosteine Imp | N/A |
Emtricitabin Oxide Impurity | 152128-77-3 |
Emtricitabine Carboxylic Acid Impurity # 120701_C | 1238210-10-0 |
PRAMIPEXOLE IMP D/Pramipexole EP Impurity D; Pramipexole BP Impurity D; Pramipexole USP Related Compound D | 104632-28-2 |
ZOFENOPRILAT IMP OF ZOFENOPRIL | 75176-37-3 |
ZOLMITRIPTAN R – ISOMER | 139264-24-7 |
13-O (TRIETHYLOSOFYL/13-O- (Triethylsilyl) Baccatin III/Paclitaxel - In House Impurity/ Paclitaxel 13- TES- Baccatin III | 208406-86-4 |
FESOFETERDINE FUMERATE (ALDEHYDE IMP F/IMP5) (WHITE VIAL) | N/A |
FESOFETERDINE FUMERATE (DEHYDROXY IMP A) (WHITE VIAL) | N/A |
SILVER | N/A |
RUTHENIUM DIOXIDE | N/A |
HYDROCORTISONE DIMER IMP N | N/A |
HYDROCORTISONE IMP I | N/A |
LISINORIL DES-PROLINE DIMER-2 | N/A |
LEVOCLOPESARTINE/ (S)-Cloperastine | 132301-89-4 |
LANSO-SULFONE IMP B/ LANSO SULFONE (LANSOPRAZOLE EP IMP B) LANSOPRAZOLE REL COMP A | 131926-99-3 |
LANSO 5-HYDROXY IMP (95.7%) /5-HYDROXY DEXLANSOPRAZOLE | 131926-98-2 |
GEMFIBROZIL IMP I | 141905-25-9 |
4-2-METHYL PROPYL PIPERIDIPINE (PREGABALIN) PREGABLIN (PG-2)/(4- ISOBUTYRLPIPERDIDNE) | 916982-10-0 |
PREGABLIN PG-2 / 4-2-METHYL PROPYL PIPERIDIPINE (PREGABALIN) PREGABLIN (PG-2)/(4-ISOBUTYRLPIPERDIDNE) | 916982-10-0 |
LIDOCOINE IMP H | 1131-01-7 |
LIDOCOINE IMP A | 87-62-7 |
IRBESARTAN DIMETHYL IMP | N/A |
PREGABALIN FR-4 CRUDEV | N/A |
PREGABALIN 174 (FR-2) | N/A |
PREGABALIN 192 (FR-3) | N/A |
PREGABALIN | N/A |
P-CRESOL SULPHATE | 91978-69-7 |
FINGOLIMOD HEPTYL | 745767-97-9 |
FINGOLIMOD DIMETHYL IMP | 1404433-87-9 |
2-AZASPIROL/ 2-azaspiro 4.5decan 3 one/GABAPENTIN RC4 | 1197-80-4 |
2-CHLORO-1,3-DIMETHYL | 37091-73-9 |
PREGABLIN / S-3Aminomethyl 5 methyl acid/(S)-Pregabalin | 148553-50-8 |
ALPHA CYCLOPENTYL MANDELIC ACID /2- Cyclopentyl-2-hydroxy-2- phenylacetic Acid/USP GLYCOPYROLATE REL COMP C | 427-49-6 |
1,3-CHLOROPHENYL-1-HYDROXY-2- | N/A |
9-4-ACETOXYLYL-BUT-2-AMINOPURINE (99.94%) | N/A |
9-4-ACETOXYLYL-BUT-2-AMINOPURINE (FOR NMR SOLVANT=DMSO) | N/A |
Famciclovir Monomesylated Impurity | N/A |
Fenbendazole F-1 compound | N/A |
Fenbendazole F-2 compound | 58306-67-5 |
Fenbendazole Thio Compound (FTC) | 43156-47-4 |
Fenbendazole Thiourea Complex | 34840-23-8 |
Fenofibrate Impurity C | 217636-47-0 |
Fenofibrate Impurity C | 217636-47-0 |
Fenofibrate Impurity D / Fenofibric Acid Ethyl Ester | 42019-07-8 |
Fenofibrate Impurity E/ | 42019-08-9 |
Fenofibrate Impurity F | 154356-96-4 |
Fenofibrate Impurity F | 154356-96-4 |
Fenofibrate Impurity G /Fenofibrate USP Related Compound C | 217636-48-1 |
Fenofibrate Related Compd A/Fenofibrate EP Impurity A | 42019-78-3 |
Fenofibrate Related Compd B/Fenofibric Acid/ Fenofibrate EP Impurity B | 42017-89-0 |
Fexofenadine Impurity B | 479035-75-1 |
Fexofenadine Related Compd C (As HCl) - Impurity C | N/A |
Fluconazole Imp A (EP) - Isomer Impurity ( 4-Isomer) | N/A |
Fluconazole Impurity --- (1H-1,2,4- triazole) | 288-88-0 |
Fluconazole Related Comp. C / Fluconazole EP Impurity C | 514222-44-7 |
Fluticasone Propionate Carbothioic Acid Impurity | 8047-45-9 |
Fluticasone Propionate Impurity A | 65429-42-7 |
Fluticasone Propionate Related Compd - Impurity B | 948566-12-9 |
Formoterol Fumarate Impurity C | 1795135-61-3 |
Formoterol Fumarate Impurity H | 1337876-26-2 |
Formoterol Fumarate Impurity H | 1337876-26-2 |
Flutamide Impurity C | 13312-12-4 |
Folic Acid | 59-30-3 |
Folic Acid IMP B | 4271-30-1 |
Folic Acid IMP F | N/A |
Fluticasone Propionate Related Compd E | N/A |
Fluconazole Related Comp. C | 514222-44-7 |
Fluconazole Impurity --- (1H-1,2,4- triazole) | 288-88-0 |
FLUMENZIL IMPURITY E | 78756-03-3 |
FLUMENZIL IMPURITY F | 151262-93-0 |
Gabapentine Related Compound A | 64744-50-9 |
Gabapentine Related Compound E USP | 67950-95-2 |
Gatifloxacin Related Compound A | 616205-76-6 |
Gatifloxacin Related Compound B | 112811-57-1 |
Gatifloxacin Related Compound C | N/A |
Glimepiride Ethyl carbamate | N/A |
Glimepiride Related Compound B | 119018-29-0 |
Glimepiride IMPURITY D | 791104-62-6 |
Glucose anhydrous | N/A |
6-CHLORO FAMCICLOVIR | N/A |
FAMCICLOVIR RELATED COMPOUND B | 104227-88-5 |
FLUTANIDE | N/A |
Fructose | N/A |
MESALAZINE IMP B/3-aminophenol | 591-27-5 |
MESALAZINE IMP D/3-aminobenzoic acid | 99-05-8 |
MESALAZINE IMP I | 3147-53-3 |
MESALAZINE IMP J | 112725-89-0 |
MESALAZINE IMP O | 121-57-3 |
6,7 Dimethoxyisoquinoline/Backebergine | 15248-39-2 |
FlecainideIMP A | HLPL/FL/07 |
2,6-DIBROMO-4- TRIFLUROMETHOXY ANILINE | 88149-49-9 |
EDTG TIOTROPIUM IMP E | N/A |
TIOTROPIUM IMP F | N/A |
TIOTROPIUM BROMIDE EP IMP E | N/A |
TIOTROPIUM BROMIDE B | N/A |
TACROLIMUS 19 EPIMER | 144490-63-1 |
TACROLIMUS RING OPEN | 1393890-33-9 |
MONOSODIUM N- TRICHOLORO | N/A |
4-ISOBUTLACETO PHENONE | 32846-01-8 |
IBRUTINIB (DIPIPERDINE) | N/A |
Pantoprazole N-OXIDE | 953787-60-5 |
PANTAPRAZOL SULPHIDE IMP B | 102625-64-9 |
PANTAPRAZOLE REL COMP A (SULPHONE) | 122780-16-9 |
R-SULFALAZINE | N/A |
3-INDOXY SULPHATE POTASSIUM | N/A |
2,3 DICHOLORO CYNAIDE (HLPL-LAMO- 01-1) 2,3-DICHOLRO BENZOYL CYNIDE/ LAMOTRIGINE IMPURITY 1 | 77668-42-9 |
HLPL-LAMO-01-A (HLPL) | N/A |
LOSARTAN IMP L | 230971-71-8 |
LOSARTAN IMP M | 230971-72- 9 |
PIOGLITAZONE IMP A/(5-4-2-5-ETHYL PYRIDINYL | 625853-74-9 |
OSELTAMIVIR IMP A | 1391047-93-0 |
VALSARTSN IMP B | 952652-79-8 |
N,N-DIYCLOHEXYLCARBODIIMIDE | 538-75-0 |
DUSTASTERIODIMP D | N/A |
4-CHOLORO ACETANILIDE /4-CHOLORO ACETANILIDE USP Acetaminophen Related Compound J; Paracetamol EP Impurity J | 539-03-7 |
1,2 DIETHYLBENZYL | 135-01-3 |
PREGABALIN PEAK 4 (174) WHITE VIAL | N/A |
PREGABALIN (174.9) | N/A |
TRAMADOL TABLETS | N/A |
IBRUTINIB DIMER 4 | 2031255-23-7 |
OSELTAMIVIR IMP D | O:1346604-18-9 |
DESMETHYL LEVOFOXCIN / LEVOFOXCIN REL COMPOUND A | 117707-40-1 |
Hydrochlorothiazide Impurity A/ Chlorothiazide | 58-94-6 |
Hydrochlorothiazide Impurity B Benzothiadiazine Related Compound A; | 121-30-2 |
Hydrochlorothiazide Impurity B Benzothiadiazine Related Compound A | 121-30-2 |
Hydrochlorothiazide Impurity C | 402824-96-8 |
Hydrochlorothiazide Impurity C | 402824-96-8 |
Hydrochlorothiazide Impurity C | 402824-96-8 |
Iloperidone N-Oxide | 1375651-09-4 |
Indapamide Impurity B (Flash isolated) | 63968-75-2 |
Ipratropium Bromide Impurity E - N- Isopropyl Noratropine | 22235-81-0 |
Ipratropium Bromide Impurity F Ipratropium Bromide Impurity E - N- Isopropyl Noratropine | 22235-81-0 |
Ivabradine N-oxide | N/A |
Itraconazole Imp B EP | 854372-77-3 |
Indapamide Impurity B (Flash isolated) | 63968-75-2 |
Ibuprofen rel comp C | N/A |
Lamivudine Impurity A | 173829-09-9 |
Lamivudine Carboxylic Acid (Impurity A) | 173602-25-0 |
Lamivudine Impurity A (Carboxylic Acid) | 173602-25-0 |
Lamivudine Impurity A (Carboxylic Acid) | 173602-25-0 |
Lamivudine Impurity G & H CAS NO/N/A | N/A |
Lamivudine Impurity G & H | N/A |
Lamivudine Impurity J / Uracil Derivative / | 145986-07-8 |
Lamotrigine Related Compound E ---- Lamotrigine Impurityt | N/A |
Lamotrigine Related Compound E ---- Lamotrigine Impurity | 1246819-06-6 |
Leflunomide Impurity D (INH) / 5-Desmethyl-3-methyl Leflunomide | N/A |
Leflunomide EP Impurity E 5-Desmethyl-3methyl Leflunomide Leflunomide EP Impurity E | 208401-20-1 |
Lenalidomide Hydroxy Impurity | N/A |
Levalbuterol Related Compound C | 18910-70-8 |
Levalbuterol Related Compound E / O-Ethyl Albuterol | 754926-25-5 |
Levetiracetam Related Compound B | 7682-20-4 |
Levofloxacin - Decarboxy Levofloxacine | N1797099-76-3 1797510-34-9 |
Levofloxacin N-Oxide/Oxifloxacin EP Impurity F | 117678-38-3 |
Levofloxacin Related Compound A/(N- DESMETHYL LEVOFOXCIN / LEVOFOXCIN REL COMPOUND A) | 117707-40-1 |
Losartan Impurity K (Losartan Aldehyde) | 114798-36-6 |
Lamivudine Impurity J / Uracil Derivative /Lamivudine Impurity J / Uracil Derivative | 145986-07-8 |
Levetiracetam Related Compound A | 173829-09-9 |
Lansoprazole Related Compound A/ LANSO-SULFONE IMP B/ LANSO SULFONE (LANSOPRAZOLE EP IMP B) LANSOPRAZOLE REL COMP A | 131926-99-3 |
2- Hydroxybenzimidazole/ Lansoprazole EP Impurity D (Rabeprazole EP Impurity K) | 615-16-7 |
Ketoprofen rel comp A / Ketoprofen EP Impurity D/rac-4’-Methyl Ketoprofen | 107257-20-5 |
KETOTIFEN N-OXIDE | 88456-70-6 |
4-ISOMER OF FLUCONAZOLE | N/A |
LEFLUNOMIDE IMPURITY C(BP)/ Leflunomide Related Compound C/Leflunomide EPImpurity C | 61643-23-0 |
LEFLUNOMIDE IMPURITY D | 208401-20-1 |
LENOLIDOMIDE | N/A |
QUETIPINE IMPURITIES/Quetiapine EP Impurity G | 3159-07-7 |
LORATADINE IMP EP B/USP Loratadine Related Compound C | 31251-41-9 |
Itraconazole EP Impurity C/Propyl Itraconazole | 74855-91-7 |
LEFLUNOMIDE IMPURITY D | 208401-20-1 |
L-PHENYLALANINE/ Aspartame EP Impurity C | 63-91-2 |
LANSOPRAZOLE IMPURITY RT 7.7 | N/A |
Itraconazole imp G | N/A |
GLIMPIRIDE IMP A | 684286-46-2 |
PROGESTRONE IMP 1 LOT NO:ALL-PRO-1 | N/A |
PROGESTRONE IMP II LOT NO:ALL-PRO-II | N/A |
PROGESTRONE IMP II LOT NO:ALL-PRO-II | N/A |
PROGESTRONE IMP E | 5062-62-4 |
PROGESTRONE IMP L | N/A |
PROGESTRONE IMP H | 1162-56-7 |
PROGESTRONE IMP K | 17652-16-3 |
TESTOSTERONE EP IMP D | 1156-92-9 |
TESTOSTRONE ENANTHATE IMP E | N/A |
GLICLAZIDE IMP D | 1136426-19-1 |
2-ETHOXYTETRA-2H PYRAN | 4819-83-4 |
MOMETASONE IMP D | HLPL-01 |
MOMETASONE DMC | N/A |
MOMETASONE SDM | N/A |
MELPHALAN IMPURITY C | 573704-41-3 |
LAMIVUDINE IMP EP G/ LAMIVUDINE IMP BP G/ LAMIVUDINE S ISOMER LAMIVUDINE IMP G / LAMIVUDINE SULFOXIDE | 160552-55-6 |
ESOMEPRAZOL IMP B | 110374-16-8 |
10-ACETOACETYL PACLITAXEL | N/A |
SUCCINYL MONOCHOLINE SUCCINNYL MONOCHOLINE CHLORIDE {2-[(3-Carboxypropanoyl)} | 5297-17-6 |
FLUTICASONE PRIOPIONATE IMP C | 80474-24-4 |
FLUTICASONE PRIOPIONATE IMP B | 948566-12-9 |
FLUTICASONE IMP A REJECTED | 65429-42-7 |
FLUTICASONE PRIOPIONATE IMP A | 65429-42-7 |
FLUTICASONE IMP D | 73205-13-7 |
FLUTICASONE DIMER IMP G | N/A |
RABEPRAZOLE SODIUM | 117976-90-6 |
ERYTHROMYCIN IMP B/N-Demethyl Erythromycin A/USP Clarithromycin Impurity R | 992-62-1 |
ERYTHROMYCIN IMP D/Anhydro Erythromycin A/Erythromycin Anhydride | 23893-13-2 |
ERYTHROMYCIN IMP L/N-Formyl Erythromycin A | 127955-44-6 |
ERYTHROMYCIN IMP G | N/A |
ERYTHROMYCIN IMP F/Pseudo CHEMICAL NAME Erythromycin A Enol Ether | 105882-69-7 |
ERYTHROMYCIN IMP C/ CHEMICAL NAME:Erythromycin E | 41451-91-6 |
ERYTHROMYCIN IMP E/ CHEMICAL NAME:Erythromycin A Enol Ether | 105882-69-7 |
ERYTHROMYCIN IMP C/ CHEMICAL NAME:Erythromycin E | 33396-29-1 |
ERYTHROMYCIN IMP I/ CHEMICAL NAME:Erythralosamine | 546-57-6 |
ERYTHROMYCIN IMP K/ CHEMICAL NAME:Erythromycin D | 33442-56-7 |
ERYTHROMYCIN IMP C/ CHEMICAL NAME:Erythromycin E | 992-65-4 |
ERYTHROMYCIN IMP H | 992-65-4 |
ERYTHROMYCIN IMP J | 105900-46-7 |
RiVASTIGMINE RELATED COMP C | 139306-10-8 |
TRAMADOL IMP B | 66170-32-9 |
N-NITROSO N-METHYL -4-AMINOBUTRIC ACID | 61445-55-4 |
LEVONORGESTRAL INTERMEDIATE | N/A |
LEVONORGESTRAL API | N/A |
Doxazosin Related Compound D | 3663-80-7 |
1-hydroxy-2azaspiro 4.5 decane GABAPENTIN RC 5 | CT-17-07-01 |
PREGABLIN IMP E/F | N/A |
DICLOFENAC IMP (26-DICHLORDIPHENYLAMINE) | 15307-93-4 |
FORMETROL FUMERATE IMP A/FORMETROL RELATED COMPOUND A | 150513-24-9 |
Doxazosin Related Compound B | 28888-44-0 |
NORFLOXCIN IMP A | 68077-26-9 |
HYCOSINE BUTYL BROMIDE | N/A |
MONTELUKEST METHYL KETONE | 937275-23-5 |
MONTELUKEST SULPHOXIDE | 909849-96-3 |
ELUXADOLINE T3298 BIS ACID/ S)-4(2- (TERT-BUTOXYCARBONYL)AMINO) | 2762439-10-9 |
6-HYDOXY A,3-BENZOXLATHIOL-2-0NE | N/A |
STYRENE | 100-42-5 |
N-(2-PHENACETURIC ACID) | 500-98-1 |
Hippuric Acid (Benzoyglycine) | 495-69-2 |
6,7-DIMETHYL DEHYDRO DROSPIRONE | 673-72-69-4 |
ATOVAQUOENE ETHANONE | N/A | S
ARTESUNATE PEROXYHEMIACETAL IMPURITY | N/A |
INS-AOO2-124P | N/A |
GLIMIPIRDE RC C | N/A |
FORMETROL IMP A/ FORMETROL 50MG, FEW MG BOX-9 FUMERATE IMP A/FORMETROL RELATED COMPOUND A | 150513-24-9 |
ALBUTEROL IMPURITY O / Salbutamol Impurity O Sulfate Salt (HYGROSCOPIC) | 18559-94-9 |
4-METHYLACETOPHENONE/Celecoxib Impurityp-Tolyl Methyl Ketone; | 122-00-9 |
192 (WHITE VIAL)192 | N/A |
MELAMINE MONOMER HLPL-MEL-202 | 106-78-1 |
LINEZOLID RELATED COMPOUND A /Deacetamide Linezolid Azide | N/A |
Dicyanodiamide;/N-Cyanoguanidine/METFORMIN EP IMPURITY A Metformin Related Compound A USP | 461-58-5 |
HLPL-CSL-Q | N/A |
GABAPENTIN GA RC 7 | N/A |
1-hydroxy-2azaspiro 4.5 decane GABAPENTIN RC 5 | N/A |
GABAPENTIN GA RC 7 | ABS-CR30-24-01 |
ACETYLCESTINE IMPURITY D (HYGROSCOPIC) | CASNO:5550-75-4 |
TELMISARTAN (ATOVAUONE) | N/A |
Repaglinide API | N/A |
Repaglinide | N/A |
Repaglinide | N/A |
Mefenamic Acid Impurity B | 21122-68-9 |
Mefenamic Acid Impurity C /(2-chlorobenzoic acid) | 118-91-2 |
Mefenamic Acid Impurity D (Benzoic acid) | 65-85-0 |
Mefenamic Acid Impurity E / 2,3-Dimethyl-N-phenylaniline | 4869-11-8 |
Metformin Related Compound B/ ---Metformin Imp E | 1674-62-0 |
Methylparaben Impurity A / p- Salicylic Acid/ 4-Hydroxybenzoic Acid/ Propylparaben Impurity A | 99-96-7 |
Metoprolol Succinate impurity G 2-(4- hydroxyphenyl)ethanol | 501-94-0 |
Metronidazole impurity A (Tinidazole Related Compound A)(Tinidazole Impurity A) | 696-23-1 |
Montelukast Cis Isomer | N/A |
Montelukast Methyl Ketone | 937275-23-5 |
Moxifloxacin 7-Amino Impurity | 172426-88-9 |
Moxifloxacin Decarboxylated Compound | N/A |
Moxifloxacin HCl Impurity E | N/A |
NIFEDIPINE IMP A/ NIFEIPINE NITROPHENYL PYRIDINE ANALOGUE Nifedipine EP Impurity A | 67035-22-7 |
Naproxen Impurity K | 77301-42-9 |
Naproxen Impurity L | 3900-45-6 |
Naproxen Impurity N | 5111-65-9 |
Nelfinavir Sulphone Impurity | 1041389-29-0 |
Nifedipine Impurity A (Nifedipine Nitrophenylpyridine Analog) | 67035-22-7 |
Nifedipine Impurity B (Nifedipine Nitrosophenylpyridine Analog) | 50428-14-3 |
Nimesulide Impurity C | 2688-84-8 |
Nimesulide Impurity D | 5422-92-4 |
Metformin Related Compound C (2,4- DIAMINO-6-DIMETHYLAMINO-1,3,5-) TRIAZINE | 1985-46-2 |
Mometasone Furoate Stage-II (i.e. Impurity D ) | 83881-09-8 |
Nelfinavir thiophenol dimer imp | 882-33-7 |
Mometasone difuroate | N/A |
Methocabamol USP (WS) | N/A |
Methocarbamol USP (WS) | N/A |
MONOPIVOXIL ADIFOVIR IMPURITY | :142341-05-7 |
IPRATORIUM EP IMPURITY A/Ipratropium USP RC A | 58005-18-8 |
METROPROLOL SUCCINATE IMPURITY B /4-(2-METHOXYETHYL)PHENOL | 5671-71-9 |
N-DESMETYHL TRIMEBUTINE HYDROCHLORIDE | N/A |
4-NITROIMIDAZOLE (METRONIDAZOLE IMPURITY B) | 102804-77-3 |
METHOXY RABEPRAZOLE IMPURITY C | 102804-77-3 |
N-ACETYL-N-PHENYL-2,6-DICHLOROANILINE | 84803-53-2 |
MALTITOL WS | N/A |
N-(1-ADAMANTYL) ACETAMIDE | 153559-48-9 |
NIFEDIPINE IMPURITY B/ Nifedipine Impurity B (Nifedipine Nitrosophenylpyridine Analog) | 50428-14-3 |
Ofloxacin Impurity A Ofloxacin Q acid from Levofloxacin Q-acid ethyl ester LVF- 03 compd)/ | 879562-26-2 |
Olmesartan Medoximil Related Compound A | 144689-24-7 |
Olmesartan Medoximil Related Compound A | 144689-24-7 |
Olmesartan Medoxomil Impurity A | 144689-24-7 |
Omeprazole Impurity F&G-Mixture | CAS NO:125656-82-8/ |
Omeprazole Impurity F&G-Peak 1 --- Grey Solid | CAS NO:125656-82-8/125656-83-9 |
Omeprazole Impurity F&G-Peak 2 --- Brown Solid | |
Ondansetron Related Compound A/Ondansetron EP Impurity A/ | CAS NO:119812-29-2 |
Oseltamivir Carboxylic Acid Impurity OSELTAMIVIR IMP C , | 187227-45-8 |
Ondansetron Related Comp C | N/A |
Olmesartan Medoximil imp D | 144690-92-6 |
OLMESARTAN RNH 8276 | N/A |
Pantoprazole Related Compound A (Sulphoxide) SULFONE/ PANTAPRAZOLE REL COMP A (SULPHONE) | 122780-16-9 |
Phenylephrine 4,6-DMTQ Impurity (Peak-1) | 23824-24-0 |
Phenylephrine 4,8-DMTQ Impurity (Peak-2) | 23824-25-1 |
Piroxicam Impurity A (Pyridin-2-amine/ 2- Amino pyridine) | 504-29-0 |
Piroxicam Impurity F | 76508-37-7 |
Praziquantel Related Compound A | 504-29-0 |
Praziquantel Related Compound C CAS | 125273-88-3 |
L-PHENYLALANINE/ Aspartame EP Impurity C | 63-91-2 |
Propylparaben Impurity A / Methylparaben Impurity A / p-Salicylic Acid/ 4-Hydroxybenzoic Acid/ | 99-96-7 |
Pyrantel Related Compound A | N/A |
Phenazone Impurity A | 89-25-8 |
Octenidine dihydrochloride | 70775-75-6 |
Piracetam Impurity C | 61516-73-2 |
Piracetam Impurity C | 61516-73-2 |
Potassium Clavulanate Impurity C / Clavulanate Potassium EP Impurity A | 4744-51-8 |
Potassium Clavulanate Impurity A / Clavulanate Potassium EP Impurity A | 4744-51-8 |
Working standard/ secondary standard Potassium Clavulanate Purified (REJECTED) | N/A |
Olanzapine imp D / Olanzepine USP Related Compound C/Olanzapine N- Oxide | 174794-02-6 |
Ofloxacin Imp E / Desmethyl Ofloxacin/ CAS NO: 82419-52-1 | 82419-52-1 |
OLMESARTAN IMP C RNH 6363 / Dehydro Olmesartan Medoxomil/ Olmesartan EP Impurity C | 879562-26-2 |
OLOPATADINE E ISOMER CRUDE | 949141-22-4 |
OLOPATADINE E ISOMER | 949141-22-4 |
OLMESARTAN DIMER | 1454571-97-1 |
DES N METHYL OLAZARDINE | N/A |
OMEPRAZOLE IMP C/Omeprazole Sulfide Esomeprazole EP Impurity C / (Omeprazole Sodium EP Impurity C) | 73590-85-9 |
OMEPRAZOLE SODIUM IMP C/ OMEPRAZOLE IMP C/Omeprazole Sulfide Esomeprazole EP Impurity C / | 73590-85-9 |
OLMESARTAN RNH 6373/ Olmesartan Imp RNH 6373 : OLMESARTAN IMP C, Dehydro Olmesartan Medoxomil | 879562-26-2 |
FORMETROL IMP A/ FORMETROL FUMERATE IMP A/FORMETROL RELATED COMPOUND A | 50513-24-9 |
oxcarbazepine rel comp B | N/A |
Ranitidine HCl Impurity E | 219921-94-5 |
Ropinirole Isatin Impurity C | N/A |
Salbutamol Impurity G / Benzylsalbutamon | 64092-10-0;24085-08-3(HClsalt) |
Salbutamol Impurity I -Levalbuterol Rel Compd F | 56796-66-8 174607-68-2 |
Salmeterol impurity A | 94749-02-7 |
Salmeterol impurity B | 9749-02-7 |
Salmeterol impurity G/ SALMETEROL DIMER IMP G / Salmeterol EP impurity G | 1391051-88-9 |
Sulfamethoxazole Impurity A | 21312-10-7 |
Sulfamethoxazole Impurity B | 135529-16-7 |
Sulfamethoxazole Impurity C | 1072-67-9 |
Sulfamethoxazole Impurity D | 121-57-3 |
Sulfamethoxazole Impurity E | 63-74-1 |
Sumatriptan Amino Impurity | 88919-22-6 |
Spironlactone | N/A |
Spironlactone imp F | 976-71-6 |
25-Desacetyl Rifampicin | 16783-99-6 |
3-(Isonicotinoylhydrazonomethyl) | 1329253-0 |
25-Desacetyl Rifampicin | 16783-99-6 |
25-Desacetyl Rifampicin | 16783-99-6 |
Salicylic Acid Related Compound A ( 4- Hydroxybenzoic acid) Aspirin Impurity A/ Propylparaben Impurity A / Methylparaben Impurity A / p- Salicylic Acid/ 4-Hydroxybenzoic Acid/ | 99-96-7 |
Salmeterol impurity H | 1330076-52-2 |
Rivastigmine imp E | 923035-05-6 |
Rivastigmine imp D | 1346242-31-6 |
Sucrose WS | 57-50-1 |
Ramipril imp E / Ramiprilat | 87269-97-4 |
Salmeterol imp F | 636-46-2 |
Rivastigmine rel comp D | 1346242-31-6 |
RITONAVIR IMP E/ Hydroxy Ritonavir | 176655-56-4 |
SALICYCLIC ACID IMP B | 19152-93-3 |
Rivastigmine rel comp D | 855300-09-3 |
Torsemide Related Compound A/ Torsemide EP IMPURITY B | 72811-73-5 |
trans cinnamaldehyde | 14371-10-9 |
Tropicamide imp A | 33403-97-3 |
Terbinafine HCl E-isomer | N/A |
Venlafaxine N-Oxide | 1094598-37-4 |
Zidovudine Impurity C | 65-71-4 |
voriconazole imp C | 137234-88-9 |
Valproic acid imp B | N/A |
Ursodeoxycholic Acid Impurity E (Deoxycholic acid) | 83-44-3 |
Timolol maleate WS 120405 | N/A |
VALACICLOVIR EP IMP M / N-Formyl Valacyclovir | 181289-15-6 |
3-ISOBUTYLGUTARIC ACID | 75143-8994 |
PREGABLIN PG-2/4-2-METHYL PROPYL PIPERIDIPINE (PREGABALIN) PREGABLIN (PG-2)/(4-ISOBUTYRLPIPERDIDNE) | 86393-331 |
CYCLIZINE IMP B | 91-01-0 |
CHLOROTIAZIDE/Hydrochlorothiazide EP Impurity A | 58-94-6 |
CARBAMAZEPINE IMP E / (10,11-DIHYDRO-5H-DIBENZ) | 124750-51-2 |
D-PROLINE | 344-25-2 |
Amisulpride EP Impurity E 4-AMINO-5-EHYLSULFNYL | 71675-87-1 |
D-LEUCINE | 328-38-1 |
2-AMINOPHENYL SULFIDE | 1134-94-7 |
1-choloro-2-nitrobennzene | 88-73-3 |
TETRA O ACETYL | (13035-61-5) |
SULFASALAZINE | 599-79-1 |
METHYL D-LACTATE | 17392-83-5 |
PREGABLIN IMP PG-3 | 75143-89-4 |
SIMASTAVIN IMP D | 476305-24-5 |
BIS VALAYCLOVIR | N/A |
AMOLIDPINE IMP A | 88150-62-3 |
BECLOMETHASONE DIPROPIONATE / Betamethasone Dipropionate EP Impurity E | 5534-09-8 |
Citalopram IMP B | 411221-53-9 |
Citalopram IMP D/ Citalopram USP RC D ; | CAS # 62498-67-3 (base) ;
97743- 99-2 (HCl) ; 1188264-72-3 (HBr) |
2-amino-9(4-hydroxy-3- (hydroxymethyl)butyl)-1h-purin-6(9h) | 39809-25-1 |
ERYTHROMYCIN IMP B | 992-62-1 |
ERYTHROMYCIN IMP E | 41451-91-6 |
CLARITHROMYCIN A/ Clarithromycin Impurity A (USP) | 124412-58-4 |
CLARITHROMYCIN O / Clarithromycin Impurity O (USP) | 127182-44-9 |
CLARITHROMYCIN G / Clarithromycin Impurity G (USP) | 127182-44-9 |
Rosuvastatin ethyl ester | NO:851443-04- |
ALBUTEROL REL COMP A | 2044704-54-4 |
Rosuvastatin ethyl ester (3R5S,6E)(4-FLUROPHENYL) | 15942-08-2 |
trans-4-(6,8-Dibromo-1,4- dihydro- 3(2H)- quinazolinyl)cyclohexanol Hydrochloride; NA 873 Hydrochloride; Ambroxol EP Impurity B Hydrochloride; | 15942-08-2 |
4-Isobutylpyrrolidin-2-one,Preg relatedcompound C | 61312-87-6 |
Veratric acid | 93-07-2 |
Methyl Hydroxy benzoate | 99-76-3 |
Propyl parahydroxybenzoate | 94-13-3 |
2'-;-Hydroxyacetanilide Acetaminon RCC | 614-80-2 |
4-Propionamidophenol /Acetaminophen related compound B | 1693-37-4 |
3-4-AMINO-2- METHYLPYRIMID 3-(((4- amino-2-methylpyrimidin- 5- yl)methyl)thio)-5- hydroxypentan-2- one20041947 Aquigen mg 25*4 THIAMINE IMPURITY 4 (in house) | N/A |
Guanine | 73-40-5 |
CEFUROXIME AXETIL (6R,7R)-3-[[(Aminocarbonyl)oxy]methyl]- 7-[[(2Z)-2-(2-furanyl)-2- (methoxyimino)acetyl]amino]-8-oxo-5- thia-1-azabicyclo[4.2.0]oct-2-ene-2- carboxylic Acid 1-(Acetyloxy)ethyl Este | 64544-07-6 |
AMIKACIN SULPHATE 1-N-[L-(-)-γ-Amino-α- hydroxybutyryl]kanamycin A Sulfate | NO:64544-07-6 |
AMIKACIN SULPHATE 1-N-[L-(-)-γ-Amino-α- hydroxybutyryl]kanamycin A Sulfate | 149022-22-0 |
Steric acid conjugate | N/A |
CAPRIC ACID CONJUGATE | N/A |
PALMITIC ACID CONJUGATE HLPL-PAC02 | N/A |
OXYBUTNIN REL COMPOUND B CAS NO:10399-13-0 | N/A |
4-ISOBUTYLACETOPHENONE Ibuprofen Related Compound C; Ibuprofen EP Impurity E | 38861-78-8 |
CLOPIDOGREL REL COMP B/ CLOPIDOGREL EP IMP | 144750-52-7 |
CLOPIDOGREL REL COMP C/ CLOPIDOGREL EP IMPURITY C | 120202-71-3 |
ATORVASTATIN REL COMP B | 887196-25-0 |
OXYBUTNIN REL COMPOUND C | N/A |
ATORVASTATIN REL COMP B | 887196-25-0 |
OXYBUTNIN REL COMPOUND C | N/A |
ATORVASTATIN REL COMP D | 148146-51-4 |
ATORVASTATIN REL COMP H | 125995-03-1 |
RILUZOLE IMPURITY II (IMPURITY II) | 175275-17-8 |
TRIETHYLENE GLYCOL | 112-27-6 |
PHENYL EPHIRINE | 939-38-8 |
Salicylic Acid/ 2-Hydroxybenzoic Acid/Acetylsalicylic Acid EP Impurity C (Aspirin Impurity C)/ Mesalazine EP Impurity H | 69-72-7 |
5-methoxynaphthalene-1,4-dione | 4923-61-9 |
1,3-DINITROSOGUANIDINE IMPURITY | N/A |
ISOBUTENE | 115-11-7 |
CYCLOPENTYL BROMIDE (SAMPLE) | 137-43-9 |
TETRABUTYLAMMONIUM HYDROXIDE | 2052-49-5 |
4-CHLOROBUTYL CHLORIDE | 111-44-4 |
2,3-DICHLOROBENZOYL | 77668-42-9 |
TETRABUTYLAMMONIUM ACETATE | 10534-59-5 |
4-CHLOROBUTYL CHLORIDE | 4635-59-0 |
Ethylene Glycol Mono-tert-butyl Ether | 7580-85-0 |
Methyl Methacrylate (stabilized with 6- tert-Butyl-2,4-xylenol) | 80-62-6 |
4-Bromo-1,2-methylenedioxybenzene | 2635-13-4 |
4-Nitropyridine N-Oxide | 1124-33-0 |
2,3,5-trifluoro-4-hydroxybenzoic acid, 99% | 156839-10-0 |
2,3,6-trifluorophenol, 95% | 3457-48-5 |
1,2-Di-p-tolylethane-1,2-dione | 41351-30-8 |
(2,4-dimethoxyphenyl)(4- hydroxyphenyl)methanone | 41351-30-8 |
Name Of The Impurity | Chemical Name | CAS Code | Structure Of The Impurity |
---|---|---|---|
Acetazolamide EP Impurity-A | N-(5-chloro-1,3,4-thiadiazol-2- yl)acetamide | 60320-32-3 | |
Acetazolamide EP Impurity-B | N-(1,3,4-thiadiazol-2-yl)acetamide | 5393-55-5 | |
Acetazolamide EP Impurity-C | N-(5-mercapto-1,3,4-thiadiazol-2- yl)acetamide | 32873-56-6 | |
Acetazolamide EP Impurity-D | 5-amino-1,3,4-thiadiazole-2- sulfonamide | 14949-00-9 | |
Acetazolamide EP Impurity-E | 5-acetamido-1,3,4-thiadiazole-2- sulfonic acid | 827026-60-8 | |
Acetazolamide EP Impurity-F | N-[5-[(5-Acetamido-1,3,4-thiadiazol-2- yl)sulfonyl]sulfamoyl-1,3,4-thiadiazol- 2-yl]acetamide | 80495-47-2 | |
Acetazolamide EP Impurity-G | 5-amino-1,3,4-thiadiazole-2-thiol | 2349-67-9 | |
Aripiprazole EP Impurity A | 7-hydroxy-3,4-dihydroquinolin-2(1H)- one | 22246-18-0 | |
Aripiprazole EP Impurity B & USP Related Compound C | 1-(2,3-dichlorophenyl)piperazine | 41202-77-1 | |
Aripiprazole EP Impurity C | N ClN 7-(4-(4-(2-chlorophenyl)piperazin-1- yl)butoxy)-3,4-dihydroquinolin-2(1H)- | 203395-81-7 | |
Aripiprazole EP Impurity D | 7-(4-(4-(3-chlorophenyl)piperazin-1- yl)butoxy)-3,4-dihydroquinolin-2(1H)- one | 203395-82-8 | |
Aripiprazole EP Impurity E & USP RC G | 7-(4-(4-(3-chlorophenyl)piperazin-1- yl)butoxy)-3,4-dihydroquinolin-2(1H)- | 203395-82-8 | |
Aripiprazole EP Impurity E & USP RC G | 7-(4-(4-(2,3-dichlorophenyl)piperazin- 1-yl)butoxy)quinolin-2(1H)-one | 129722-25-4 | |
Aripiprazole EP Impurity F | 4-(2,3-dichlorophenyl)-1-(4-((2-oxo- 1,2,3,4-tetrahydroquinolin-7- yl)oxy)butyl)piperazine 1-oxide | 573691-09-5 | |
Aripiprazole N,N- Dioxide | 1-(2,3-dichlorophenyl)-4-(4-((2-oxo- 1,2,3,4-tetrahydroquinolin-7- yl)oxy)butyl)piperazine 1,4-dioxide | 573691-13-1 | |
Aripiprazole USP Related Compound H | 7-(4-{4-[4-(2,3- Dichlorophenyl)piperazin-1- yl]butoxy}butoxy)-3,4-dihydro quinolin-2(1H)-one | 1796928-63-6 | |
Chloromethyl laurate | chloromethyl dodecanoate | 61413-67-0 | |
methylene didodecanoate | methylene didodecanoate | 1261134-88-6 | |
Argatroban Related Compound A in USP | (2R,4R)-4-Methyl-1-((S)-2-(3- methylquinoline-8-sulfonamido)5-(3- nitroguanidino)pentanoyl)piperidine- 2-carboxylic acid | 74874-10-5 | |
Argatroban Related Compound C in USP | (2R,4R)-1-[N8-amino-N2-(3- methylquinoline-8-sulfonyl)-L-arginyl]- 4-methylpiperidine-2carboxylic acid | N/A | |
Dehydroargatroban | (2R,4R)-4-Methyl-1-(((3- methylquinolin-8-yl)sulfonyl)-L- arginyl)piperidine-2-carboxylic acid | 951130-92-0 | |
Argatroban Impurity 1 | (2R,4R)-4-methyl-1-((2S)-2-((3- methyl-1,2,3,4-tetrahydroquinoline)- 8-sulfonamido)-5- ureidopentanoyl)piperidine-2- carboxylic acid | 2423016-01-5 | |
Argatroban Impurity 2 | (S)-2-(3-methylquinoline-8- sulfonamido)-5-(3- nitroguanidino)pentanoic acid | NA | |
Argatroban Impurity 3 | (2R,4R)-4-methyl-1-(N2-((3-methyl- 1,2,3,4-tetrahydroquinolin-8- yl)sulfonyl)-Nw-nitro-L- arginyl)piperidine-2-carboxylic acid | NA | |
Argatroban Impurity 4 | Ethyl (2R,4R)-4-methylpiperidine-2- carboxylate | 74892-82-3 | |
Argatroban Impurity 5 | (2R,4R)-4-methylpiperidine-2- carboxylic acid | 74892-81-2 | |
Argatroban Impurity 6 | 3-Methylquinoline-8-sulfonic acid | 153886-69-2 | |
Bortezomib USP Impurity B & Bortezomib Amide Analog | (2S)-3-Phenyl-2-[(pyrazin-2- ylcarbonyl)amino]propanamide | 289472-80-6 | |
Bortezomib Acid Impurity & Bortezomib USP Impurity D | (2S)-3-Phenyl-2-[(pyrazin-2- ylcarbonyl)amino]propanoic acid | 114457-94-2 | |
Bortezomib Pinanediol Impurity | N-[(1S)-2-[[(1R)-1- [(3aS,4S,6S,7aR)-Hexahydro- 3a,5,5-trimethyl-4,6-methano-1,3,2- benzodioxaborol-2-yl]-3- methylbutyl]amino]-2-oxo-1- (phenylmethyl)ethyl]-2- pyrazinecarboxamide | 205393-22-2 | |
Bortezomib USP Impurity H | ((R)-3-methyl-1-((R)-3-phenyl-2- (pyrazine-2- carboxamido)propanamido)butyl)bo ronic acid | 1132709-15-9 | |
Bortezomib USP Impurity G | [(1S)-3-Methyl-1-({(2S)-3-phenyl-2- [(pyrazin-2- ylcarbonyl)amino]propanoyl} amino)butyl]boronic acid | 1132709-14-8 | |
Bortezomib Enantiomer | ((S)-3-methyl-1-((R)-3-phenyl-2- (pyrazine-2- carboxamido)propanamido)butyl)bo ronic acid | 1132709-16-0 | |
Bortezomib Hydroxy (1S, 2R)-Isomer | N-[(2R)-1-{[(1S)-1-Hydroxy-3- methylbutyl]amino}-1-oxo-3- phenylpropan-2-yl]pyrazine-2- carboxamide | NA | |
Bortezomib Hydroxy (1S, 2R)-Isomer | N-[(2R)-1-{[(1S)-1-Hydroxy-3- methylbutyl]amino}-1-oxo-3- phenylpropan-2-yl]pyrazine-2- | NA |